AstraZeneca buys Spanish drug company's respiratory franchise for up to $2.1B
July 30, 2014 at 09:32 AM EDT
AstraZeneca agreed on Wednesday to buy Almirall’s respiratory disorder treatment franchise in a deal valued at up to $2...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.